Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Porphyrazine optical and dual optical/MR contrast and therapeutic agents

Porphyrazine optical and dual optical/MR contrast and therapeutic agents

US Patent 8540967 · Granted Sep 24, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds 2024
Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2023
Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2021
Ln(III) and Ga(III) metallacrown complexes2020
Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2019
Metallacrown complexes and methods of making the same2019
Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their ther2018
Process for preparing 5,7 diaminopyrazolo [1,5-A] pyrimidine compounds2013
Method for the generation of a set of conflicts for model-based system diagnosti2012
Selective inhibitors for cyclin-dependent kinases2011
Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers1999
Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers1999